Sahitya Allam MD , Alexander Hajduczok MD , Philipp Sommer FHRS, FESC, FEHRA , Nishaki Mehta MD, FHRS
{"title":"Atrial Fibrillation Incidence, Outcomes, and Management in Patients with Left Ventricular Assist Devices and Orthotopic Heart Transplants","authors":"Sahitya Allam MD , Alexander Hajduczok MD , Philipp Sommer FHRS, FESC, FEHRA , Nishaki Mehta MD, FHRS","doi":"10.1016/j.ccep.2024.10.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39250,"journal":{"name":"Cardiac Electrophysiology Clinics","volume":"17 1","pages":"Pages 99-107"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiac Electrophysiology Clinics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877918224000595","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
左心室辅助装置和原位心脏移植患者心房颤动的发生率、结果和处理。
本文探讨了关于左心室辅助装置和原位心脏移植患者心房颤动(AF)发病率、结局和管理的现有知识,以及导管消融等新兴技术。由于每组房颤的病理生理机制不同,它强调了个性化护理的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。